Grape King Bio Ltd (葡萄王) last month saw revenue reach a record high of NT$990 million (US$32.91 million), reversing annual declines in revenue since the previous August and lifting revenue for the whole year to flat from 2018, the company said on Monday.
Sales momentum came from its Taiwanese operations and its direct-sales subsidiary, Pro-Partner Inc (葡眾), with revenue rising 26 percent to NT$50.39 million and 9.5 percent to NT$852.54 million respectively, company data showed.
Local operations’ sales rose thanks to its anniversary sales promotion, the “Double 12” shopping event last month and increasing consumer awareness of its products, the company said.
Probiotics and health foods ranked first in terms of sales generated by its Taiwanese operations, followed by the energy drink Come Best and nutritional supplements that contain turmeric, Grape King communications officer James Chao (趙光正) said by telephone.
Pro-Partner’s sales were buoyed by the launch of new products such as a dried powder containing lactic acid bacteria and health food for pets, Chao said.
Whole-year revenue generated by its Taiwanese operations expanded 32.5 percent from a year earlier to NT$537.76 million, while the direct-sales unit reported a rise of 4.8 percent to NT$7.79 billion, company data showed.
Both are expected to see further growth this year, as Pro-Partner is to launch two products, while the local units would likely cooperate with a Japan-based manufacturer of supplements, API Co Ltd, Chao said.
However, Shanghai Grape King Enterprises Corp (上海葡萄王) reported a drop in revenue for the ninth consecutive month, plunging 41 percent to NT$87.64 million, company data showed.
The unit’s whole-year revenue plummeted 34 percent to NT$910.27 million, Grape King said.
Sales generated by its Chinese operations would likely rebound after March as it expects increasing demand from new clients, it said in a statement.
Grape King’s revenue stood at NT$9.23 billion for the whole of last year, up 0.17 percent from a year earlier.
Zhang Yazhou was sitting in the passenger seat of her Tesla Model 3 when she said she heard her father’s panicked voice: The brakes do not work. Approaching a red light, her father swerved around two cars before plowing into a sport utility vehicle and a sedan, and crashing into a large concrete barrier. Stunned, Zhang gazed at the deflating airbag in front of her. She could never have imagined what was to come: Tesla Inc sued her for defamation for complaining publicly about the vehicles brakes — and won. A Chinese court ordered Zhang to pay more than US$23,000 in
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday held its first board of directors meeting in the US, at which it did not unveil any new US investments despite mounting tariff threats from US President Donald Trump. Trump has threatened to impose 100 percent tariffs on Taiwan-made chips, prompting market speculation that TSMC might consider boosting its chip capacity in the US or ramping up production of advanced chips such as those using a 2-nanometer technology process at its Arizona fabs ahead of schedule. Speculation also swirled that the chipmaker might consider building its own advanced packaging capacity in the US as part
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday said that its investment plan in Arizona is going according to schedule, following a local media report claiming that the company is planning to break ground on its third wafer fab in the US in June. In a statement, TSMC said it does not comment on market speculation, but that its investments in Arizona are proceeding well. TSMC is investing more than US$65 billion in Arizona to build three advanced wafer fabs. The first one has started production using the 4-nanometer (nm) process, while the second one would start mass production using the
‘NO DISRUPTION’: A US trade association said that it was ready to work with the US administration to streamline the program’s requirements and achieve shared goals The White House is seeking to renegotiate US CHIPS and Science Act awards and has signaled delays to some upcoming semiconductor disbursements, two sources familiar with the matter told reporters. The people, along with a third source, said that the new US administration is reviewing the projects awarded under the 2022 law, meant to boost US domestic semiconductor output with US$39 billion in subsidies. Washington plans to renegotiate some of the deals after assessing and changing current requirements, the sources said. The extent of the possible changes and how they would affect agreements already finalized was not immediately clear. It was not known